Study Evaluating Bifeprunox in Patients With Schizophrenia.

Stopped early · Phase 3

Conditions studied: Schizophrenia

In brief

An open-label extension study using a variable dose (20 to 30 mg daily) of bifeprunox to evaluate long-term safety.

Key facts

Study ID

NCT00366327

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

400

Starts

2007-01-01

Expected to finish

2008-03-01

Last updated by the study team

2013-02-11

Who can join

Age: 18 and older, up to 66. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Outpatients who have successfully completed Wyeth study 3168A1-313.
• A signed and dated informed consent form for this study.
• No major protocol violations in the previous study.

You may not qualify if…

• Clinically important abnormalities in the preceding short-term study that have not resolved.
• Use of prohibited treatments in the preceding short-term study.
• Meeting any exclusion criteria in the preceding short-term study

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — Anaheim, California, United States
• Study site — Anaheim, California, United States
• Study site — Anaheim, California, United States
• Study site — Boynton Beach, California, United States
• Study site — Buena Park, California, United States
• Study site — Cerritos, California, United States
• Study site — Costa Mesa, California, United States
• Study site — Costa Mesa, California, United States
• Study site — Escondido, California, United States
• Study site — Garden Grove, California, United States
• Study site — Glendale, California, United States
• Study site — Huntington Beach, California, United States
• Study site — La Mesa, California, United States
• Study site — National City, California, United States
• Study site — Oceanside, California, United States
• Study site — Paramount, California, United States
• Study site — Rosemead, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — San Diego, California, United States
• Study site — San Diego, California, United States
• Study site — Santa Ana, California, United States
• Study site — Santa Ana, California, United States
• Study site — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.